Abstract

Viral infectious diseases are a global health concern, as is evident by recent outbreaks of the middle east respiratory syndrome, Ebola virus disease, and re-emerging zika, dengue, and chikungunya fevers. Viral epidemics are a socio-economic burden that causes short- and long-term costs for disease diagnosis and treatment as well as a loss in productivity by absenteeism. These outbreaks and their socio-economic costs underline the necessity for a precise analysis of virus-host interactions, which would help to understand disease mechanisms and to develop therapeutic interventions. The combination of quantitative measurements and dynamic mathematical modeling has increased our understanding of the within-host infection dynamics and has led to important insights into viral pathogenesis, transmission, and disease progression. Furthermore, virus-host models helped to identify drug targets, to predict the treatment duration to achieve cure, and to reduce treatment costs. In this article, we review important achievements made by mathematical modeling of viral kinetics on the extracellular, intracellular, and multi-scale level for Human Immunodeficiency Virus, Hepatitis C Virus, Influenza A Virus, Ebola Virus, Dengue Virus, and Zika Virus. Herein, we focus on basic mathematical models on the population scale (so-called target cell-limited models), detailed models regarding the most important steps in the viral life cycle, and the combination of both. For this purpose, we review how mathematical modeling of viral dynamics helped to understand the virus-host interactions and disease progression or clearance. Additionally, we review different types and effects of therapeutic strategies and how mathematical modeling has been used to predict new treatment regimens.

Highlights

  • Viruses are small obligate intracellular parasites that are unable to reproduce independent of their host

  • We describe the latest achievements made by modeling the dynamics of Ebola Virus (EBOV), Dengue Virus (DENV), and Zika Virus (ZIKV) that caused the most recent viral outbreaks

  • For more than 20 years, the population-based target cell-limited model has been used to describe the dynamics of a variety of viruses

Read more

Summary

INTRODUCTION

Viruses are small obligate intracellular parasites that are unable to reproduce independent of their host. To include the effect of direct acting antivirals (DAAs), the target cell-limited model can be further extended by more detailed intracellular processes of the viral life cycle (Figure 1C). These multi-scale models that take the age of infected cells into account allow a biologically more realistic representation of intracellular processes with age-dependent reaction rates (Quintela et al, 2017). Infected but not yet virus producing cells (I1) in the eclipse phase become productively virus producing cells (I2) with average transition time

Note that
MODELING HIV INFECTIONS
Viral Dynamics
Antiretroviral Therapy
HEPATITIS C VIRUS
Antiviral Treatment
Direct Acting Antivirals
Host Factor Targeting and Intracellular Models
INFLUENZA VIRUS
Viral Dynamics and Immune Response
Risk Factor Age
Antiviral Drugs
Ebola Virus
Dengue Virus
Zika Virus
Findings
CONCLUSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.